We currently can help with the purchase of Sinovac CoronaVac, which obtained conditional market approval by China’s National Medical Products Administration on February 5th, 2021.
It is an inactivated COVID-19 vaccine developed by domestic drugmaker Sinovac Biotech. Sinovac Life Sciences Co Ltd on February 3rd filed an application for conditional market approval of CoronaVac, which was granted on the basis of the vaccine’s overseas phase-3 clinical trials for two months.
-Purchase order from Ministry of Public Health or CDC (provincial or above, preferably national);
-Letter of Intent/ Procurement Letter;
-1 box (1 dose): 10cm*6cm*2.5cm, weight is below 50gram.
-50w boxes: volume is around 75 cubic meters, weight is around 25 tons.